Evidence map›Paper›PMID 42797291›Full record

ArticlePharmaceutics2026

A Locally Injectable, pH/ROS-Responsive Hydrogel Platform for Combination Therapy of Cervical Cancer with Anti-Fibrotic and Chemotherapeutic Agents.

Qian Chen, Hui Yang, Meili Pei, Yanxia Sun, Yubei Li, Sen Yu, Xiaofeng Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qian ChenDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Hui YangShaanxi Key Laboratory of Biomedical Metallic Materials, Northwest Institute for Non-Ferrous Metal Research, Xi'an 710014, China.ORCID 0000-0001-6883-4632
Meili PeiDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Yanxia SunDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Yubei LiDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Sen YuShaanxi Key Laboratory of Biomedical Metallic Materials, Northwest Institute for Non-Ferrous Metal Research, Xi'an 710014, China.
Xiaofeng YangDepartment of Gynecology and Obstetrics, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

Funding

National Natural Science Foundation of China Grant No. 22302159Precision Prevention and Treatment Innovation Team Project for Cervical Cancer 2023-CX-TD-68Science Fund for Distinguished Young Scholars of Shaanxi 2024JC-JCQN-31Shaanxi Provincial Health Commission Scientific Research Innovation Platform Project for Precision and Standardized Diagnosis and Treatment of Gynecological Oncology 2024PT-11
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer-associated fibroblastscervical cancerdual-responsive hydrogelhomotypic targeting nanoparticlestumor microenvironment

Identifiers

PMID42797291
PMCPMC13610339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.